Radiolabeled probes for tumor hypoxia imaging

Key Points

• Imaging tumor hypoxia with radiolabeled probes enhances diagnostic capabilities, and improves treatment outcomes.
• The study highlights radiolabeled probes as innovative biomarkers for identifying hypoxic tumors effectively.
• Assessment using advanced imaging techniques provides crucial insights on the physiological status of tumors.
• The findings may enable targeted therapies and personalized treatment plans for cancer patients based on tumor oxygen levels.